Ireland-based DS Biopharma has appointed Leopoldo Zambeletti as a non-executive director to help the company advance its portfolio of bioactive lipids to treat inflammatory skin and pulmonary disorders. An accountant and investment banker, Mr Zambeletti has led healthcare investment teams at both JP Morgan and Credit Suisse. Since 2013 he has been an independent strategic advisor to life science companies on merger and acquisition and financing strategy. Mr Zambeletti started his career as an accountant at KPMG.
DS Biopharma announced the appointment on 25 September 2015.
Copyright 2015 Evernow Publishing Ltd